Patents by Inventor Andrew Gordon Werner

Andrew Gordon Werner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF USING AND COMPOSITIONS CONTAINING DULAGLUTIDE
    Publication number: 20200330558
    Abstract: The present invention relates to methods of using new doses of dulaglutide and compositions containing such higher doses of dulaglutide.
    Type: Application
    Filed: November 13, 2018
    Publication date: October 22, 2020
    Inventors: David Andrew Cox, Zvonko Milicevic, Lai San Tham, Andrew Gordon Werner, David Bradley Woodward
  • Anti-IL-17 Antibodies
    Publication number: 20080269467
    Abstract: Anti-IL-17 antibodies are identified that are characterized as having a high affinity and slow off rate for human IL-17. The antibodies of the invention may be chimeric, humanized or fully human antibodies, immunoconjugates of the antibodies or antigen-binding fragments thereof. The antibodies of the invention are useful in particular for treating autoimmune, inflammatory, cell proliferative and developmental disorders.
    Type: Application
    Filed: December 5, 2006
    Publication date: October 30, 2008
    Inventors: Barrett Allan, Chi-Kin Chow, Lihua Huang, Ling Liu, Jirong Lu, Kingman Ng, Jonathan Wendell Tetreault, Andrew Gordon Werner